Vertical Chart, Sky-High Multiple - I Bought Palantir Anyway

Hook & thesis

Palantir just delivered the sort of quarter that makes you wince at the valuation and then pause because the customer metrics are simply too good to ignore. Q3 revenue came in at $2.31 billion, up 96% year-over-year, with U.S. commercial revenue surging 148% to $984 million and eclipsing government revenue for the first time. Yet the market is pricing enormous future growth into the stock - roughly a $421 billion market cap and what amounts to an earnings multiple north of 120x. That combination is arresting: ridiculous on the surface, compelling underneath.

I'm taking a controlled long here. The trade is not a blanket endorsement of the multiple - it is a tactical play on momentum, customer economics, and a vertical chart that is signaling a buyer-dominant market. Entry: $175.41. Stop: $150.00. Target: $240.00. Time horizon: long term (180 trading days). Here's why I own PLTR even though the valuation looks absurd.

What Palantir does and why it matters

Palantir builds data platforms that become the operational backbone for customers - combining integration, analytics, and workflow automation with AI models trained on proprietary customer data. Its two segments - Commercial and Government - have historically been weighted toward the public sector, but Q3 shows a structural shift as commercial customers scale deployments and pay up for measurable ROI embedded in operations.

Why the market should care: Palantir sells deep, sticky software that can justify high effective prices if it measurably improves outcomes. Management now emphasizes delivering AI into workflows - not just dashboards - and that moves the product from nice-to-have analytics to mission-critical automation. The company reported a net dollar retention rate of 165% and remaining deal value of $6.52 billion. Those are the metrics that support sustained top-line expansion if execution holds.

Hard numbers that matter

• Q3 revenue: $2.31 billion, +95.9% YoY (reported).
• U.S. commercial revenue: $984 million, +148% YoY and now larger than government revenue.
• EPS: ~$0.44 for Q3 beat expectations; trailing EPS data show an annual EPS around ~$1.26 in the most recent filings.
• Valuation: market cap approximately $421.5 billion, price-to-earnings in the neighborhood of ~125x (highly elevated by any conventional metric).
• Liquidity and technicals: average volume near 25.6M shares (30-day average ~23.7M), current RSI ~36 (cooling), and short interest days-to-cover ~2.4 - so shorts exist but covering pressure is limited.

Valuation framing - why 'ridiculous' doesn't end the story

At face value, Palantir's multiple is punitive for a conventional software multiple framework. Price-to-sales and P/E metrics imply the market expects a decade of hyper-growth to justify the current price. That said, some context softens the panic: the company is growing nearly 100% YoY and guiding to very high growth rates for the full year (management raised guidance to about 91% growth). If Palantir can sustain accelerated net dollar retention, expand commercial pricing power via AI workflows, and convert a sizable portion of the $6.52 billion remaining deal value into revenue, the lofty multiple becomes an aggressive—but not impossible—projection of future earnings.

Even so, my approach treats valuation as a reason for position sizing and tight stops, not a fatal flaw. This is a classic 'high conviction, high risk' trade: you either get paid if the company out-executes or you accept the loss if growth disappoints and the market re-rates.

Technical and market structure case

The chart action matters for this idea. The stock has shown a vertical move and large intraday volumes - today's range was $165.25 to $176.54 with heavy volume (~52.6M shares traded). Momentum indicators cooled (RSI ~35.8; MACD showing bearish momentum), which argues for a measured entry rather than aggressive averaging up. Still, average volume is elevated compared to earlier in the year, and short-volume data show frequent short activity—an ingredient for squeezes if positive news continues.

Catalysts (2-5)

• Ongoing commercial deal conversions from the $6.52 billion remaining contract value - each large conversion reduces path risk to revenue targets.
• Execution on AI Platform (AIP) integrations that move the product from analytics to embedded workflow automation - proof points here would materially affect longevity of high pricing power.
• Further upward guidance or improved retention metrics in upcoming quarters - management has already raised guidance for the year; more clarity helps justify multiples.
• Partnerships or marquee enterprise wins in healthcare, energy, or finance that demonstrate cross-industry applicability outside government.

Trade plan

This is a tactical, size-controlled long with explicit risk controls. I treat this as a directional momentum play that needs room to run but must also respect the stretched valuation.

Why 180 trading days? The thesis depends on multi-quarter execution on large commercial deals and AIP deployments. Expect meaningful revenue recognition and margin improvements to materialize over several quarters; 180 trading days gives time for at least two reporting events and multiple sales-cycle catalysts.

Risks - what could go wrong

This is a high-risk trade. Key failure modes include:

• Valuation re-rating: If investors lose conviction, the stock can compress violently from current multiples - a re-rate toward more reasonable P/E multiples would erase significant market value even if revenue grows.
• Contract deceleration: Headlines already hinted at slowing contract value growth in some reports; if remaining deal value converts slower than expected, top-line beats may be one-offs rather than sustainable growth.
• Customer concentration and procurement cycles: Large enterprise government deals are lumpy. Timing risk could cause sequential misses even with sound secular demand, pressuring the multiple.
• Competition & model risk: The AI software market is intensely competitive. Cheaper or better-integrated alternatives could steal share, or open-source commoditization could pressure pricing power.
• Macro/ sentiment shock: Given how stretched the valuation is, broader market weakness or a liquidity shock could cause outsized downside irrespective of company performance.

Counterarguments to my buy

Reasonable investors will point out that paying 125x earnings is speculative even for a fast-growing software company. Critics also highlight the recent headlines about decelerating contract value growth and the risk that net dollar retention and remaining deal value are noisy metrics that can fall apart with execution slip-ups. Those counterarguments are valid. I accept them and therefore keep position size small, set a firm stop, and require further verification from subsequent quarters before increasing exposure.

What would change my mind

I'll reduce or exit the position if one of the following happens:

• Missed revenue or retention guidance in the next two quarters, or a visible drop in remaining deal value conversion rates.
• Management signals structural pricing pressure or rising churn rather than upsell-driven expansion.
• Technical breakdown below the $150 stop on heavy volume, which would indicate the market is re-pricing risk materially higher.

Conclusion - pragmatic contrarian play

Palantir is the kind of company that polarizes markets: exceptional growth and customer metrics on one hand, and valuations that assume near-perfect execution on the other. I bought into strength because the commercial transformation is real, the unit economics (165% net dollar retention) are compelling, and the chart shows buyer dominance. But this is not a conviction buy for a full-sized position - it's a tactical, size-limited long that acknowledges the valuation risk and uses strict stops.

If Palantir executes on AIP integrations and converts a meaningful share of the remaining deal value, the upside to $240 and beyond is plausible within 180 trading days. If it doesn't, the stop at $150 preserves capital and forces reassessment. That balance - aggressive entry, disciplined risk - is why I'm long even when the market thinks the price is ridiculous.

Entry: $175.41 | Stop: $150.00 | Target: $240.00 | Horizon: long term (180 trading days)